Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0618 CHF | -4.04% | +4.75% | +50.73% |
May. 01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SPEXIS AG | Biopharmaceuticals | -4.04% | +4.75% | +50.73% | -84.78% | - | 4.63M |
Technical Rankings Surperformance
- Stock Market
- Equities
- POLN Stock
- Charts Spexis AG
- Comparison Chart